Episodic muscle tremors in a quarter horse: resemblance to hyperkalemic periodic paralysis

A three year old Quarter Horse stallion was presented with a one year history of episodes of generalized muscle tremors and stiffness, and spasm of the muscles of facial expression, lasting 10-15 minutes. Between attacks, the horse was either normal or had a localized muscle tremor in the flank region. Episodes appeared unrelated to exercise. The major abnormal findings included 1) a rise in plasma potassium from a resting level of 4.4 to 7.9 mmol/L during an attack and 2) electromyographic findings of generalized increased insertion activity and myotonic discharges. The horse was treated with hydrochlorothiazide tablets for nine months, during which time no further attacks were noted. However, four months after the drug was stopped, sporadic focal muscle tremors reappeared; two months later, generalized attacks were seen. Despite reinstitution of the diuretic, a focal flank tremor persisted. Two related horses in the same stable also were reported by the owner to exhibit sporadic generalized muscle twitching. The abnormal findings of the present case differ from clinical syndromes previously reported in horses. Some similarities to hyperkalemic periodic paralysis in humans are noted.     

Arteriovenous fistula in the orbit of a calf

An Ayrshire calf with a protruding left eye and a fluctuant swelling dorsal to the orbit was examined. A diagnosis of arteriovenous fistula was made based on the findings of pulsation, a palpable thrill and a machinery-like bruit on auscultation over the swelling. Arteriography failed to outline the full extent of the fistula. The calf was euthanized and the fistula dissected. An enlarged superficial temporal artery communicated with a branch of the maxillary vein by way of a tortuous mass of vessels. The frontal bone was eroded by this plexus.     

Use of clomipramine in the treatment of anxiety-related and obsessive-compulsive disorders in cats

Objective To evaluate the efficacy and tolerance of a treatment protocol for anxiety-related and obsessive-compulsive disorders in cats.
Design A study was undertaken to assess the clinical response in cats diagnosed with anxiety-related or obsessive-compulsive disorders to a treatment regimen that included clomipramine and behaviour modification.
Procedure The study group of 11 cats was acquired through referral. A detailed behavioural and clinical history was obtained. Presenting signs were urine spraying in seven cases, overgrooming in three and excessive vocalisation in one. Clomipramine was administered orally once daily. The mean starting dose was 0.4 mg/kg. If necessary, the dose was adjusted according to the clinical response of each cat. A behaviour modification program was designed and the owner instructed on its implementation. Cats were to continue on medication for at least 1 month after clinical signs disappeared, then medication withdrawal was to be attempted by decreasing the clomipramine dose progressively at weekly intervals while the behaviour modification program continued.
Results In all cases the presenting clinical sign was largely improved or disappeared. One cat was removed from the study by the owner. Four cats became lethargic at higher doses, but this resolved when the clomipramine dose was reduced. The average maintenance dosage was 0.3 mg/kg once daily. Clomipramine withdrawal was attempted in two cases: the behaviour returned in one case and the medication was reinstated at 0.3 mg/kg twice daily.
Conclusion Clomipramine was effective in controlling the signs of anxiety-related and obsessive-compulsive disorders in 10 of 10 assessable cases when used in combination with behaviour modification. Clomipramine was well tolerated.     

Treatment and control by vaccination of erysipelas in farmed emus (Dromaius novo-hollandiae)

Objective To study erysipelas in farmed emus and the treatment and control of the disease by vaccination.
Design A retrospective study of field outbreaks in emus and challenge experiments in mice using field and vaccine strains of the organism.
Procedure Outbreaks of the disease were described. Field strains of the organism were identified and tested by challenge experiments in mice against commercial vaccine strains.
Results Erysipelas was characterised by sudden death in yearling emus. Deaths mainly occurred during the cold wet months. Mortalities of 6 to 10% were seen within the first 7 to 10 days of an outbreak. Clinical signs were uncommon but some birds exhibited lethargy and greenish diarrhoea. Necropsy findings included marked petechial haemorrhages on the serosal surface of the large intestine in particular, pericardial effusion and congestion and mottling of the liver. Treatment consisted of individual or mass medication with procaine penicillin, reduction of stress factors such as overcrowding, and spelling and rotation of paddocks. Isolates from two field outbreaks were identified as strain 21. Complete protection was provided by a commercial strain 2b vaccine against challenge by strain 21 field isolates in mice. Annual vaccination of birds at 4 weeks and again at 8 weeks of age appeared to control further outbreaks on farms where the disease had previously occurred and vaccination appeared to protect for at least 12 months.
Conclusion Treatment of birds with antibiotics may be feasible in the face of an outbreak. However, annual vaccination of birds with an appropriate vaccine is recommended.     

Effects of residues of deltamethrin in cattle faeces on the development and survival of three species of dungbreeding insect

Objective To assess the toxicity to insects of drug residues excreted in cattle faeces following treatment with deltamethrin.
Design Bioassays were performed on one species of dung-breeding fly ( Musca vetustissima ) and two species of dung beetle ( Onthophagus binodis and Euoniticellus fulvus ).
Animals Cattle on properties near Kangaroo Valley, Canberra and Gundagai were treated with pour-on formulations of deltamethrin. Untreated animals acted as controls.
Procedures Faeces from treated and untreated cattle were inoculated with newly emerged fly larvae or fed to adults of two species of dung beetle. Percentage survival and duration of development provided measures of the toxicity of deltamethrin residues in faeces.
Results Residues of deltamethrin were excreted in concentrations sufficient to inhibit survival of larvae of M vetustissima for 1 to 2 weeks after treatment. Peak concentrations of 0.4mg deltamethrin/kg dry weight of faeces occurred 3 days after treatment and were sufficient to kill adult beetles for at least twice this period. With one of two formulations tested, there was evidence of a reduction in dung beetle fecundity and an increase in the duration of juvenile development. A model of the effect of deltamethrin on the breeding success of dung beetles in the field suggests that a single treatment, applied when most of the population is in a non-parous condition, may cause up to 75% reduction in beetle acitivity by the end of the season. Multiple treatments at 10 or 21 day intervals may drive local populations towards extinction.
Conclusion Depending on the time and frequency of treatment, the effect of deltamethrin on insects in cattle faeces may range from negligible to catastrophic.     

Examination of metabolism of viscera drained by the portal vein in neonatal calves, using short-term intravenous infusions of glutamine and other nutrients

OBJECTIVE: To quantify glutamine use in viscera drained by the portal vein in neonatal calves and to assess the relative nutritional importance of glutamine, glucose, and acetate for enterocytes. ANIMALS: 5 healthy neonatal calves. PROCEDURE: A femoral artery, jugular vein, and the portal vein were surgically cannulated in each calf. Blood flow in the portal vein was measured by use of an ultrasonographic transit-time flow probe. A series of solutions was infused on 4 days for each calf. On the infusion days, acetate, glucose, glutamine, and saline (0.9% NaCl; control) solutions were administered IV during 1-hour periods via the jugular vein. Venous and arterial blood samples were collected during the last 15 minutes of each 1-hour infusion. RESULTS: Uptake of glutamine and glucose by viscera drained by the portal vein was 0.3+/-1.1 and 1.9+/-3.1 micromol/kg0.75/min, respectively, during saline infusion. During acetate, glucose, and saline infusions, glucose was a greater source of energy for the intestines than was glutamine. However, during glutamine infusion, uptake of glutamine by viscera drained by the portal vein increased significantly (29.9+/-11.2 micromol/kg0.75/min), which was associated with an increase in ammonia production (7.0+/-0.5 micromol/kg0.75/min). Toxicosis was not associated with IV administration of glutamine. CONCLUSION: Glutamine infusion resulted in an increase in glutamine uptake by viscera drained by the portal vein, which was associated with an increase in ammonia production and a slight increase in oxygen consumption. CLINICAL RELEVANCE: These solutions may be used to develop treatments that enhance healing of intestines of diarrheic calves.     

Mechanisms underlying Phalaris aquatica "sudden death" syndrome in sheep

Twenty outbreaks of Phalaris aquatica "sudden death" syndrome in sheep were investigated between 1981 and 1991. Four were confirmed and one was suspected, to be a cardiac disorder; 5 were confirmed and 3 were suspected, to be a polioencephalomalacic disorder; the aetiology of the remaining 7 outbreaks could not be determined. Potentially toxic levels of hydrocyanic acid (20 to 36 mg/100 g) were measured in the 3 toxic phalaris pastures tested. The measurement of potentially toxic levels of nitrate nitrogen (2920 micrograms/g) in toxic phalaris pastures by others, was noted. It is suggested that phalaris "sudden death" syndrome could have as many as 4 different underlying mechanisms, and that these might reflect the presence in the plant of a cardio-respiratory toxin, a thiaminase and amine co-substate, cyanogenic compounds, and nitrate compounds.